Cancer Vaccines — What They Are and What They Are Not

Both — but they are two entirely different kinds of medicine that share one confusing word. Preventive cancer vaccines stop a virus that can later cause cancer, and are given to healthy people. Therapeutic cancer vaccines are given to someone who already has cancer, and are still mostly experimental.

That single distinction is the whole point of this page. When a family hears “there is a vaccine for cancer”, they are almost always hearing about the first kind — the HPV vaccine or the hepatitis B vaccine — and applying it to the second. The two are not related in how they work, who they are for, or what they can do.

Preventive vaccines are vaccines against viruses. They do nothing at all to a cancer that already exists. Therapeutic vaccines are attempts to teach the immune system to recognise a tumour that is already there. Almost every therapeutic cancer vaccine in the news is still being tested in clinical trials, not prescribed in clinics. Knowing which one you are reading about protects you from both false hope and a missed prevention opportunity.

Framing follows WHO and NCCN patient-education material. This table explains categories, not your own treatment plan — only your oncologist, reviewing your reports, can say what applies to you.

Drug classes and mechanisms are described here deliberately, without naming products, because comparing branded products on a patient-education page is not appropriate and approval status differs by country.

1. 1

   A target is chosen

   Either a protein many tumours of that type carry, or, in the personalised approach, mutations found only in that one patient's tumour after sequencing.

2. 2

   The target is packaged

   As a peptide, as genetic instructions the body reads to make the protein itself, inside a harmless virus, or loaded onto the patient's own immune cells in a lab.

3. 3

   It is given, usually in a series

   Often several doses over weeks, sometimes with a substance added to make the immune reaction stronger, exactly as with a childhood vaccine schedule.

4. 4

   T cells are meant to expand and travel

   Immune cells that recognise the target multiply and move into the tumour. This is the step that most often fails, because tumours suppress immune activity around themselves.

5. 5

   It is often combined, not used alone

   Much current research pairs a vaccine with a checkpoint inhibitor, on the logic that one supplies the target and the other releases the brake. That combination is still being tested.

• Individualised neoantigen vaccines — a vaccine designed against mutations unique to one patient's tumour. In late-stage trials, not approved treatment.
• mRNA cancer vaccines — the platform familiar from infectious disease, applied to tumour targets. Under active study; results so far are early.
• Dendritic-cell vaccines — the patient's own antigen-presenting cells loaded in a lab. Studied for decades, with inconsistent results across trials.
• Peptide and whole-tumour-cell vaccines — older approaches that repeatedly produced an immune response on paper without a matching clinical benefit.
• Vaccine plus checkpoint inhibitor combinations — biologically logical, and the busiest area of current research, but not yet standard care anywhere.

Clinical trials are how these questions get answered, and taking part is a reasonable thing to consider. This page is informational only — it does not recruit for any trial and cannot promise you a place in one. If you are interested, ask your treating oncologist to look for a registered trial that matches your diagnosis. Enrolment always goes through your own team.

Anything sold as an immunity treatment outside a hospital pharmacy or a registered trial. The word vaccine is doing marketing work in a lot of places it should not be, and families under pressure are the intended audience.

• Immunity boosters and intravenous vitamin drips — these do not train the immune system against a tumour, and high-dose supplements can interact with cancer treatment. Tell your oncologist about anything you are taking.
• Cell-therapy or dendritic-cell injections offered outside a registered trial — if the practice cannot show you a regulatory approval and published evidence, treat the offer as unproven, whatever it is called.
• Herbal, homeopathic or traditional preparations described as vaccines — these systems have their own place and many families use them. The problem is the label, and the risk of an unreported interaction. Disclose, do not hide.
• Antibody-based treatments — real, effective medicines, but they are not vaccines. See Bispecific Antibodies and T-Cell Engagers for how those actually work.

CION does not administer or stock CAR-T or any cell therapy product; where that kind of treatment is genuinely relevant, patients are referred to a centre that provides it. Immunotherapy that CION does provide is given as day care at our centres, and response-assessment PET-CT is coordinated at partner imaging centres.

• BCG Therapy for Bladder Cancer: The Oldest Immunotherapy — the vaccine strain that is used as immunotherapy, and why it is not a cancer vaccine in the sense this page describes.
• Bispecific Antibodies and T-Cell Engagers — a different way of getting T cells to a tumour, built from antibodies rather than from a vaccine.
• Immunomodulators: Tablets That Work on the Immune System — the oral class that also acts on immune signalling, often confused with immunity supplements.
• Immunotherapy at CION Cancer Clinics — the hub page, covering eligibility, biomarker testing, day-care administration and cost.

This page is general information and does not replace a consultation. It names drug classes and mechanisms only, not products, and makes no comparison of efficacy between products. Vaccination decisions during cancer treatment must be made with your treating oncologist.

Families ask about cancer vaccines almost every week

It is a fair question, and it deserves a straight answer rather than a brush-off. Our team will take the time to explain what exists, what is being tested, and what is simply being sold.